If your healthcare provider prescribes an inhaler for COPD, it's important to know that different types of inhalers have different actions and uses. Some contain bronchodilators to open your airways ...

N-acetylcysteine (NAC) nebulizer therapy is effective and safe as a short-term (12-week) treatment for reducing phlegm in chronic obstructive pulmonary disease (COPD), according to study findings ...

High-intensity noninvasive positive pressure ventilation (NPPV) might have reduced need for endotracheal intubation for ...

In a report released today, Ram Selvaraju from H.C. Wainwright reiterated a Buy rating on Verona Pharma (VRNA – Research Report), with a ...

The drug was administered twice-daily using a nebuliser as a chronic maintenance therapy for people with COPD in the ENHANCE ... and is thought to combine bronchodilator and anti-inflammatory ...

Medscape Medical News, August 01, 2011 FDA Approves Once-Daily Bronchodilator for COPD As a once-a-day drug, the new long-acting beta2-adrenergic agonist promises greater patient adherence than ...

The Spanish COPD guidelines recommend treatment of the mixed COPD–asthma phenotype with ICS and a long-acting bronchodilator (LABD) as a first option to improve lung function, respiratory ...

After 12 weeks of nebulized NAC, patients’ mean phlegm scores, as measured by the COPD assessment test, significantly decreased from 3.47 at baseline to 2.62. N-acetylcysteine (NAC) nebulizer therapy ...

COPD and BPD: Inhalation of Live Lactobacilli Lessens Lung Inflammation and Improves Lung Function Aug. 21, 2024 — In preclinical models, the inhalation of a mixture of living Lactobacilli ...